Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Study of brentuximab vedotin combination treatment in people with early-stage Hodgkin lymphoma: a plain language summary.
Journal: Future oncology (London, England)
Published: July 06, 2026
Summary of Research: Brentuximab Vedotin and Nivolumab in Combination with Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin Lymphoma.
Journal: Advances in therapy
Published: May 08, 2026
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma.
Journal: Cancer research communications
Published: January 28, 2023
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: November 13, 2020
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 11, 2019
Effect of Group Dynamics-Based Exercise Versus Personal Training in Breast Cancer Survivors.
Journal: Oncology nursing forum
Published: February 16, 2019
Activity of 129 single-agent drugs in 228 phase I and II clinical trials in multiple myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 12, 2013
The clinical significance of cereblon expression in multiple myeloma.
Journal: Leukemia research
Published: May 21, 2013
A surprising cause of masses in the chest.
Journal: American journal of hematology
Published: August 06, 2012
Last Updated: 09/26/2026